Pittcon Q&A

Pittcon Q&A

February 28, 2015

Extracts from Laboratory Equipment:

Pittcon Q&A

Ahead of Pittcon 2015 in New Orleans, Editor-in-Chief Michelle Taylor spoke with experts from exhibiting companies to get their take on what to expect at both this year’s Pittcon as well as future Pittcons.

What technologies and trends do you expect to see at Pittcon 2015?

“I believe that the world of analytical (and medical) science is on a journey from analysis in the laboratory to measurement at the point of sample - and I hope that this year’s Pittcon will reflect that trend.” - Stephen Tomisich, Director and CEO, Trajan Scientific and Medical

What technologies and trends do you expect to see beyond 2015?

“Looking ahead, I expect to see more companies presenting portable instruments and the easy-to-use computing and consumable formats that this analytical shift demands.” - Stephen Tomisich, Director and CEO, Trajan Scientific and Medical

Taylor also asked our Q&A interview subjects to sum up the future of the lab industry in a few words.

Here's what they said:

“Powerful, affordable, portable analysis” - Stephen Tomisich

Read the full article at the Laboratory Equipment website.




Also in News

Advantages of hemaPEN blood microsampling validated for therapeutic drug monitoring in RSC’s Analyst
Advantages of hemaPEN blood microsampling validated for therapeutic drug monitoring in RSC’s Analyst

September 07, 2020

Trajan Scientific and Medical’s hemaPEN® has been independently evaluated and the results of the study published in the Royal Society of Chemistry’s journal Analyst - selected for the cover of issue 17. hemaPEN demonstrated significant advantages for blood sampling to support better healthcare decision making.

Read More

European patent for Trajan’s hemaPEN
European patent for Trajan’s hemaPEN

July 13, 2020

Trajan Scientific and Medical is proud to advise that the European Patent Office will be granting a patent for hemaPEN® as a liquid collection device in Belgium, France, Germany, Ireland, Luxembourg, Monaco, Switzerland, Liechtenstein and the United Kingdom. Extensions are being sought across the remainder of Europe.

Read More

US FDA listing of Trajan’s hemaPEN blood microsampling device
US FDA listing of Trajan’s hemaPEN blood microsampling device

July 02, 2020

Trajan Scientific and Medical has listed its hemaPEN® blood microsampling device with the U.S. Food and Drug Administration as Class I for therapeutic and in vitro diagnostic use. This follows the hemaPEN’s recent registration in May for supply in the EU and UK as a General IVD; as well as inclusion in the TGA’s ARTG (Australian Register of Therapeutic Goods) in February as a Class I IVD.

Read More